Nutritional support during treatment of biliopancreatic malignancy

Annals of Oncology

Volumn 10, Issue SUPPL. 4, 1999, Pages

  Von Meyenfeldt, Maarten F ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Artificial nutrition; Metabolic support; Nutrition

Indexed keywords

ARGININE; GLUTAMINE; ICOSAPENTAENOIC ACID;

ARTIFICIAL FEEDING; BILE DUCT OBSTRUCTION; BILIARY TRACT CANCER; BODY COMPOSITION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; ENERGY EXPENDITURE; HOSPITAL COST; HUMAN; INFLAMMATION; NUTRITIONAL SUPPORT; PANCREAS CANCER; PRIORITY JOURNAL; PROGNOSIS; WEIGHT REDUCTION;

EID: 0032815520     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/10.suppl_4.S273     Document Type: Conference Paper

References (82)

1. Studley HO. Percentage of weight loss. A basic indicator of surgical risk in patients with chronic peptic ulcer. JAMA 1936; 106: 458-60
2. Anker SD, Ponikowski P, Varney S et al. Wasting as an independent risk factor for mortality in chronic heart failure. Lancet 1997; 349: 1050-3
3. Griffiths RD. Muscle mass, survival, and the elderly ICU patient. Nutrition 1996; 12: 456-8.
4. Mcwhirter JP, Penninglon CR. Incidence and recognition of malnutrition in hospital. BMJ 1994; 308: 945-8
5. Campos AC, Meguid MM. A critical appraisal of the usefulness of perioperative nutritional support. Am J Clin Nutr 1992; 55: 117-30
6. Hill GL. The perioperative patient. In: Nutrition and metabolism in patient care, Kinney LM, Jeejeebhoy KN, Hill GL, Owen OE, eds. WB Saunders Comp 1988
7. Ovesen L, Allingstrup L, Hannibal J et al. Effect of dietary counseling on food intake, body weight, response rate, survival and quality of life in cancer patients andergoing chemotherapy: a prospective randomised study. J Clin Oncol 1993; 11: 2043-9
8. Falconer JS, Fearon KCH, Plester CE et al. Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer. Ann Surg 1994; 219: 325-31
9. Klein S, Kinney JM, Jeejeebhoy KN et al. Nutrition support in clinical practice: review of published data and recommendations for future research directions. Am J Clin Nutr 1997; 66: 683-706
10. Weisdorf S, Hofland C, Sharp HL et al. Total parenteral nutrition in bone marrow transplantation; a clinical evaluation. J Pediatr Gastroenterol Nutr 1984; 3: 95-100
11. Hulsewé KWE, Soeters PB, von Meyenfeldt MF. Nutrition support for the surgical patient. In: Payne James J, et al, eds. Artificial nutrition support in clinical practice, 2nd ed. Edward Arnold, Sevenoaks, UK. In press 1999
12. Warnold I, Lundholm K, Schersten T. Energy balance and body composition in cancer patients. Cancer Res 1978; 38: 1801-7
13. Lundholm K, Edstrom S, Karlberg I et al. Glucose turnover, gluconeogenesis from glycerol and estimation of net glucose cycling in cancer patients. Cancer 1982; 44: 857-61
14. Lundholm K, Holm G, Schersten T. Insulin resistance in patients with cancer. Cancer Res 1978; 38: 4665-70
15. Heslin MJ, Newman E, Wolf RF et al. Effect of systemic hyperinsulinemia in cancer patients. Cancer Res 1992; 52: 3845-50
16. Vlassara H, Spiegel RJ, San Doval D et al. Reduced plasma lipoprotein lipase activity in patients with malignancy associated weight loss. Horm Metab Res 1986; 18: 698-703
17. Jeevanandam M, Horowitz GD, Lowry SF et al. Cancer cachexia and protein metabolism. Lancet 1984; 1423-7
18. Heber D, Chlebowski RT, Ishibashi DE et al. Abnormalities in glucose and protein metabolism in noncachectic lung cancer patients. Cancer Res 1982; 42: 4815-9
19. Greve JWM, Gouma DJ, Buurman WA. Complications in obstructive jaundice: role of endotoxins. Scand J Gastroenterol 1992; 27 S 194: 8-12
20. Todorov P, Carluk P, McDevitt T et al. Characterization of a cancer cachectic factor. Nature 1996; 379: 739-42
21. Bergström J, Fürst P, Noree LO et al. Intracellular free amino acid concentrations in human muscle tissue. J Appl Physiol 1974; 36: 693-7
22. Lacey JM, Wilmore DW. Is glutamine a conditionally essential amino acid? Nutr Rev 1990; 48: 297-309
23. Elia M, Folmer P, Schlatmann A et al. Amino acid metabolism in muscle and in whole body of man before and after ingestion of a single mixed meal. Am J Clin Nutr 1989; 49: 1203-10
24. Halperin ML, Ethier JH, Kamel KS. The excretion of ammonium ions and acid base balance. Clin Biochem 1990; 23: 185-8
25. Ardawi MS, Newsholme EA. Glutamine metabolism in lymphocytes of the rat. Biochem J 1983; 212: 835-42
26. Windmueller HG. Glutamine utilization by the small intestine. Adv Enzymol Relat Areas Mol Biol 1982; 53: 201-37
27. Hong RW, Rounds JD, Helton WS et al. Glutamine preserves liver glutathione after lethal hepatic injury. Ann Surg 1992; 215: 114-9
28. Rose WC. Feeding experiments with mixtures of highly purified amino acids. J Biol Chem 1931; 74: 155
29. Fürst P, Albers S, Stehle P. Stress induced intra-cellular glutamine depletion. The potential use of glutamine containing peptides in parenteral nutrition. In: Contributions to infusion therapy and clinical nutrition. Karger, Munich. Bassler KH et al, eds. 1987; 117-36
30. Parry-Billings M, Baigrie RJ, Lamont PM et al. Effects of major and minor surgery on plasma glutamine and cytokine levels. Arch Surg 1992; 127: 1237-40
31. De Blaauw I, Deutz NEP, von Meyenfeldt MF. Cancer reduces the metabolic response of muscle to surgical stress in the rat. J Surg Res 1998 in press
32. Van der Hulst RRWJ, von Meyenfeldt MF, Soeters PB. Glutamine: an essential amino acid for the gut. Nutrition 1996; 12: S78-S81
33. Parry-Billings M, Evans J, Calder PC et al. Does glutamine contribute to immunosuppression after major hums? Lancet 1990; 336: 523-5
34. Van der Hulst RRWJ, van Kreel BK, von Meyenfeldt MF et al. Glutamine and the preservation of gut integrity. Lancet 1993; 341: 1363-5
35. O'Riordain MG, Fearon KC, Ross JA et al. Glutamine supplemented total parenteral nutrition enhances T-lymphocyte response in surgical patients undergoing colorectal resection. Ann Surg 1994; 220: 212-21
36. O'Dwyer ST, Smith RJ, Hwang TL et al. Maintenance of small bowel mucosa with glutamine enriched parenteral nutrition. JPEN 1989; 13: 579-85
37. Tamada H, Nezu R, Imamura I et al. The dipeptide alanyl-glutamine prevents intestinal mucosal atrophy in parenterally fed rats. JPEN 1992; 16: 110-6
38. Li J, Langkamp-Henken B, Suzuki K et al. Glutamine prevents parenteral nutrition induced increases in intestinal permeability in rats. JPEN 1994; 18: 303-7
39. Burke DJ, Alverdy JC, Aoys E et al. Glutamine supplemented total parenteral nutrition improves gut immune function. Arch Surg 1989; 124: 1396-9
40. Alverdy JA, Aoys E, Weiss-Carrington P et al. The effect of glutamine enriched TPN on gut immune cellularity. J Surg Res 1992; 52: 34-8
41. Yoshida S, Leskiw MJ, Schluter MD et al. Effect of total parenteral nutrition, systemic sepsis, and glutamine on gut mucosa in rats. Am J Phys 1992; 263: E368-E373
42. Harward TR, Coe D, Souba WW et al. Glutamine preserves gut glutathione levels during intestinal ischemia/reperfusion. J Surg Res 1994; 56: 351-5
43. Calder PC. Glutamine and the immune system. Clin Nutr 1994; 13: 2-8
44. Heberer M, Babst R, Juretic A et al. Role of glutamine in the immune response in critical illness. Nutrition 1996; 12: S71-S72
45. Tenenhaus M, Hansbrough JF, Zapata-Sirvent RL et al. Supplementation of an elemental diet with alanyl-glutamine decreases bacterialtranslocation in burned mice. Burns 1994; 20: 220-5
46. Dugan ME, McBurney MI. Luminal glutamine perfusion alters endotoxin related changes in ileal permeability of the piglet JPEN 1995; 19: 83-7
47. Gianotti L, Alexander JW, Gennari R et al. Oral glutamine decreases bacterial translocation and improves survival in experimental gut origin sepsis. JPEN 1995; 19: 69-74
48. Hammarqvist F, Wernerman J, Ali R et al. Addition of glutamine to total parenteral nutrition after elective abdominal surgery spares free glutamine in muscle, counteracts the fall in muscle protein synthesis, and improves nitrogen balance. Ann Surg 1989; 209: 455-61
49. Van der Hulst RRWJ, von Meyenfeldt MF, Deutz NEP et al. The effect of glutamine administration on intestinal glulamine content. J Surg Res 1996; 61: 30-4
50. Stehle P, Zander J, Mertes N et al. Effect of parenteral glutamine peptide supplements on muscle glutamine loss and nitrogen balance after major surgery Lancet 1989; 1: 231-3
51. Blomqvist BI, Hammarqvist F, von der Decken A et al. Glutamine and alpha-ketoglutarate prevent the decrease in muscle free glutamine concentration and influence protein synthesis after total hip replacement. Metabolism 1995; 44: 1215-22
52. Ziegler TR, Young LS, Benfell K et al. Clinical and metabolic efficacy of glutamine supplemented parenteral nutrition after bone marrow transplantation. A randomized, double blind, controlled study. Ann Int Med 1992; 116: 821-8
53. Griffiths RD, Jones C, Palmer TE. Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition. Nutrition 1997; 13: 295-302
54. Houdijk APJ, Rijnsburger ER, Jansen J et al. Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet 1998; 352: 772-6
55. Barbul A. Arginine: Biochemistry, Physiology, and Therapeutic Implications. JPEN 1986; 10: 227-38
56. Brittenden J, Heys SD, Ross J et al. Nutritional pharmacology: effects of L-arginine on host defences, response to trauma and tumour growth. Editorial review. Clin Sci 1994; 86: 123-32
57. Beaumier L, Castillo L, Yu Y-M et al. Arginine: new and exciting developments for an "old" amino acid. Biomed Environ Sci 1996; 9: 296-315
58. Grimble GK. Essential and conditionally essential nutrients in clinical nutrition. Nutr Res Rev 1993; 6: 97-119
59. Kirk SJ, Barbul A. Role of arginine in trauma, sepsis and immunity. JPEN 1990; 14:S226-S229
60. Houdijk AP, van Leeuwen PA, Teerlink T et al. Glutamine enriched enteral diet increases renal arginine production. JPEN 1994; 18: 422-6
61. Oka T, Ohwada K, Nagao M et al. Arginine-enriched solution induces a marked increase in muscle glutamine concentration and enhances muscle prolein synthesis in tumor-bearing rats. JPEN 1994; 18: 491-6
62. Park KG, Hayes PD, Garlick PJ et al. Stimulation of lymphocyte natural cytotoxicity by L-arginine. Lancet 1991; 337: 645-6
63. Heys SD, Segar A, Payne S et al. Dietary supplementation with L-arginine: modulation of tumour infiltrating lymphocytes in patients wilh colorectal cancer. Br J Surg 1997; 84: 238-41
64. Kelly E, Morris SM, Billiar TR. Nitric oxide, sepsis, and arginine metabolism. Review. JPEN 1995; 19: 234-8
65. Daly JM, Reynolds J, Thom A et al. Immune and metabolic effects of arginine in the surgical patient. Ann Surg 1988; 208: 512-23
66. Barbul A, Lazarou S, Efron DT et al. Arginine enhances wound healing and lymphocyte immune responses in humans. Surg 1990; 109: 331-7
67. Kirk SJ, Hurson M, Regan MC et al. Arginine stimulates wound healing and immune function in elderly human beings. Surg 1993; 114: 155-9
68. Kulkarni AD, Fanslow WC, Rudolph FB et al. Effect of dietary nucleotides on response to bacterial infectons. JPEN 1986; 10: 169-71
69. Wachler P, König W, Senkal M et al. Influence of a total parenteral nutrition enriched with ω-3 fatty acids on leukotriene synthesis of peripheral leucocytes and systemic cytokine levels in patients with major surgery. J Tra Inj Inf Crit Care. 1997; 42: 191-8
70. Schilling J, Vranjes N, Fierz W et al. Clinical outcome and immunology of postopererative arginine. ω-3 fatty acids, and nucleotide-enriched enteral feeding: a randomized prospective comparison with standard enteral and low calorie/low fat IV solutions. Nutrition 19996; 12: 423-9
71. Braga M, Vignali A, Gianotti L et al. Immune and nutritional effects of early enteral nutrition after major abdominal operations. Eur J Surg 1996; 162: 105-12
72. Daly JM, Lieberman MD, Goldfine J et al. Enteral nutrition with supplemental arginine. RNA, and omega-3 fatty acids in patiens after operation: immunology, metabolic, and clinical outcome. Surg 1992; 112: 56-67
73. Kemen M, Senkal M, Homann H-H et al. Early postoperative enteral nutrition with arginine, ω-3 fatty acids and ribonucleic acid-supplemenled diet versus placebo in cancer patients: an immunology evaluation of impact. Crit Care Mod 1995; 23: 652-659
74. Senkal M, Kemen M, Homann H-H et al. Modulation of postoperative immune response by enteral nutrition with a diet enriched with arginine, RNA, and omega-3 fatty acids in patients with upper gastrointestinal cancer. Eur J Surg 1995; 161: 115-22
75. Daly JM, Weintraub FN, Shou J et al. Enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients. Ann Surg 1995; 221: 237-338
76. Bower RH, Cerra FB, Bershadsky B et al. Early enteral administration of a formula supplemented with arginine, nucleotides and fish oil in intensive care unit patients: results of a multicenter prospective randomized trial. Crit Care Med 1995; 23: 436-49
77. Kudsk KA, Minard G, Croce MA et al. A randomized trial of isonitrogenous enteral diets after severe trauma. Ann Surg 1996; 224: 531-43
78. Endres S, Ghorbani R, Kelley VE et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. NEJM 1989; 320: 265-71
79. Meydani SN, Lichlenslein AH, Cornwall S et al. Immunologic effects of national cholesterol education panel step-2 diets with and without fish-derived n-3 fatty acid enrichment. J clin Invest 1993; 92: 105-13
80. Wigmore SJ, Ross JA, Plester CE et al. Effect of polyunsaturated fatty acids on cachexia in weight losing patients with pancreatic cancer. Nutrition 1996, 12 S: 23-6
81. Wigmore SJ, Fearon KCH, Maingay JP et al. Down-regulation of the acute-phase response in patients with pancreatic cancer cachexia receiving oral eicosapentaenoic acid is mediated via suppression of interleukin-6. Clin Science 1997; 92: 215-21
82. Barber MD, Ross JA, Tisdale MJ et al. The effect of an eicosapentaenoic acid-enriched nutritional supplement in weight-losing patients with pancreatic cancer. Abstract Clin Nutr 20th ESPEN Congress. Nice 1998